Brought to you by 
MannKind closes $81.4mm IPO
03 Aug 2004
Executive Summary
After filing for an $86.25mm initial public offering in April, MannKind (drug delivery and cancer therapeutics) revised the offering in early July to sell 5.5mm common shares between $13-15 each, to bring in up to $82.5mm. It finally completed the IPO in late July, selling 6.25mm common shares priced at $14 each, netting the company $81.4mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Pulmonary
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com